• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于弥漫性子宫内膜G2级子宫内膜样腺癌保留生育功能管理的新手术方法:分步技术

A new surgical approach for fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step-by-step technique.

作者信息

Catena U, Mirandola M, Capomacchia F M, Fanfani F, Scambia G

出版信息

Facts Views Vis Obgyn. 2023 Mar;15(1):79-81. doi: 10.52054/FVVO.15.1.058.

DOI:10.52054/FVVO.15.1.058
PMID:37010338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10392118/
Abstract

BACKGROUND

4% of endometrial cancers are diagnosed in young women and 70% are nulliparous. Preserve fertility in these patients is of major interest. It is demonstrated that hysteroscopic resection of focal well-differentiated endometrioid adenocarcinoma, followed by progestins achieve a complete response rate of 95.3%. Recently, fertility-sparing treatment was proposed also in case of moderately differentiated endometrioid tumors, with a relatively high remission rate.

OBJECTIVE

To show a new hysteroscopic approach, in case of fertility-sparing treatment of diffuse endometrial G2 endometrioid adenocarcinoma.

MATERIALS AND METHODS

Stepwise demonstration of the technique with narrated video footage for the fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma, combining the use of a 15 Fr bipolar miniresectoscope and 'three-steps' resection technique (Karl Storz, Tuttlingen, Germany) with a Tissue Removal Device (TRD) (Truclear Elite Mini, Medtronic).

MAIN OUTCOME MEASURES

negative hysteroscopic assessment and endometrial biopsies at three and six months.

RESULTS

Normal endometrial cavity and negative biopsies.

CONCLUSION

Combined hysteroscopic technique, in case of diffuse endometrial G2 endometrioid adenocarcinoma, followed by double progestin therapy (Levonorgestrel releasing Intrauterine Device + Megestrole Acetate 160 mg/daily), may be associated with higher complete response rate; the use of TRD to complete the resection near tubal ostia may reduce risk of post-operative intrauterine adhesions and improve reproductive outcomes.

WHAT IS NEW?: A novel, fertility-sparing surgical approach for diffuse endometrial G2 endometroid adenocarcinoma.

摘要

背景

4%的子宫内膜癌在年轻女性中被诊断出,其中70%未生育。保留这些患者的生育能力是主要关注点。已证实,宫腔镜切除局灶性高分化子宫内膜样腺癌,随后使用孕激素,完全缓解率达95.3%。最近,对于中分化子宫内膜样肿瘤也提出了保留生育功能的治疗方法,缓解率相对较高。

目的

展示一种新的宫腔镜方法,用于保留生育功能治疗弥漫性子宫内膜G2级子宫内膜样腺癌。

材料与方法

通过带旁白的视频片段逐步演示弥漫性子宫内膜G2级子宫内膜样腺癌保留生育功能管理的技术,结合使用15 Fr双极微型切除镜和“三步”切除技术(德国图特林根的卡尔·史托斯公司)以及组织切除装置(TRD)(美敦力公司的Truclear Elite Mini)。

主要观察指标

宫腔镜评估阴性以及术后3个月和6个月的子宫内膜活检阴性。

结果

子宫内膜腔正常且活检阴性。

结论

对于弥漫性子宫内膜G2级子宫内膜样腺癌,采用联合宫腔镜技术,随后进行双孕激素治疗(左炔诺孕酮宫内节育器+醋酸甲地孕酮160 mg/日),可能会有更高的完全缓解率;使用TRD在输卵管开口附近完成切除可降低术后宫腔粘连风险并改善生殖结局。

新内容是什么?:一种用于弥漫性子宫内膜G2级子宫内膜样腺癌的新型保留生育功能的手术方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2bf/10392118/01d0ca980e54/FVVinObGyn-15-79-qr001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2bf/10392118/01d0ca980e54/FVVinObGyn-15-79-qr001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2bf/10392118/01d0ca980e54/FVVinObGyn-15-79-qr001.jpg

相似文献

1
A new surgical approach for fertility-sparing management of diffuse endometrial G2 endometrioid adenocarcinoma: a step-by-step technique.一种用于弥漫性子宫内膜G2级子宫内膜样腺癌保留生育功能管理的新手术方法:分步技术
Facts Views Vis Obgyn. 2023 Mar;15(1):79-81. doi: 10.52054/FVVO.15.1.058.
2
Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.宫腔镜子宫内膜局灶切除术联合左炔诺孕酮宫内节育系统治疗不典型子宫内膜增生和早期子宫内膜癌的保留生育功能疗效分析:一项回顾性研究。
J Minim Invasive Gynecol. 2019 May-Jun;26(4):648-656. doi: 10.1016/j.jmig.2018.07.001. Epub 2018 Jul 11.
3
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.保留生育功能手术治疗非典型增生和子宫内膜癌的宫腔镜切除术:安全性与有效性
J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1178-82. doi: 10.1016/j.jmig.2015.06.004. Epub 2015 Jun 16.
4
Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.左炔诺孕酮宫内缓释系统联合二甲双胍与醋酸甲地孕酮联合二甲双胍用于治疗非典型子宫内膜增生和早期子宫内膜癌的保留生育功能治疗:一项前瞻性、随机、盲终点设计临床试验方案。
Reprod Health. 2022 Nov 4;19(1):206. doi: 10.1186/s12978-022-01513-8.
5
Fertility-sparing surgery for diffuse adenomyosis: a narrated, stepwise approach to the Osada procedure.弥漫性子宫腺肌病的保留生育功能手术:分步叙述的 Osada 手术方法。
Fertil Steril. 2022 Sep;118(3):588-590. doi: 10.1016/j.fertnstert.2022.06.026. Epub 2022 Aug 10.
6
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.孕激素治疗在成功使用孕激素进行保留生育功能治疗后复发的子宫内膜腺癌患者中的应用。
Gynecol Oncol. 2013 Apr;129(1):7-11. doi: 10.1016/j.ygyno.2012.12.037. Epub 2012 Dec 30.
7
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.子宫内膜样型子宫内膜癌 2 级 IA 期(FIGO)患者的保留生育力方法:定性系统评价。
Biomed Res Int. 2022 Sep 27;2022:4070368. doi: 10.1155/2022/4070368. eCollection 2022.
8
Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).保留生育功能治疗子宫内膜癌患者(FERT-ENC):来自西班牙妇科肿瘤学研究网络(SPAIN-GOG)的多中心回顾性研究。
Arch Gynecol Obstet. 2022 Sep;306(3):821-828. doi: 10.1007/s00404-021-06375-2. Epub 2022 Feb 4.
9
Hysteroscopy and weight loss in treatment of endometrial cancer: case report and literature review.宫腔镜检查联合减肥治疗子宫内膜癌:病例报告及文献复习。
Minim Invasive Ther Allied Technol. 2024 Apr;33(2):109-119. doi: 10.1080/13645706.2023.2294993. Epub 2023 Dec 18.
10
Fertility-sparing approach for endometrial cancer: the role of office hysteroscopy.保留生育功能的子宫内膜癌治疗方法:门诊宫腔镜的作用。
Minim Invasive Ther Allied Technol. 2021 Oct;30(5):296-303. doi: 10.1080/13645706.2021.1949353. Epub 2021 Jul 22.

引用本文的文献

1
Application of MRI-guided hysteroscopic one-step resection in preserving the fertility of early endometrial cancer patients.MRI引导下宫腔镜一步切除术在早期子宫内膜癌患者保留生育功能中的应用
Front Oncol. 2025 Aug 25;15:1597185. doi: 10.3389/fonc.2025.1597185. eCollection 2025.

本文引用的文献

1
Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.子宫内膜样型子宫内膜癌 2 级 IA 期(FIGO)患者的保留生育力方法:定性系统评价。
Biomed Res Int. 2022 Sep 27;2022:4070368. doi: 10.1155/2022/4070368. eCollection 2022.
2
Conservative Surgery in Endometrial Cancer.子宫内膜癌的保守性手术
J Clin Med. 2021 Dec 29;11(1):183. doi: 10.3390/jcm11010183.
3
International Consensus Statement for Recommended Terminology Describing Hysteroscopic Procedures.
国际宫腔镜操作术语推荐意见共识声明。
J Minim Invasive Gynecol. 2022 Mar;29(3):385-391. doi: 10.1016/j.jmig.2021.10.004. Epub 2021 Oct 12.
4
International Consensus Statement for recommended terminology describing hysteroscopic procedures.关于宫腔镜手术推荐术语的国际共识声明。
Facts Views Vis Obgyn. 2021 Dec;13(4):287-294. doi: 10.52054/FVVO.13.4.037. Epub 2021 Oct 13.
5
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 子宫内膜癌管理指南。
Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.
6
Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study.保留生育功能治疗子宫黏膜内、中分化型子宫内膜癌:妇科癌症国际协作组(GCIG)研究。
J Gynecol Oncol. 2020 Sep;31(5):e74. doi: 10.3802/jgo.2020.31.e74.
7
Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.宫腔镜子宫内膜局灶切除术联合左炔诺孕酮宫内节育系统治疗不典型子宫内膜增生和早期子宫内膜癌的保留生育功能疗效分析:一项回顾性研究。
J Minim Invasive Gynecol. 2019 May-Jun;26(4):648-656. doi: 10.1016/j.jmig.2018.07.001. Epub 2018 Jul 11.
8
Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives.生育期患者IA期I型和G2级子宫内膜癌的保留生育功能手术:循证方法与未来展望
Updates Surg. 2017 Mar;69(1):29-34. doi: 10.1007/s13304-017-0419-y. Epub 2017 Feb 10.
9
Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.早期子宫内膜癌年轻女性行宫腔镜切除术后孕激素治疗的生育功能保留治疗
J Gynecol Oncol. 2017 Jan;28(1):e2. doi: 10.3802/jgo.2017.28.e2. Epub 2016 Aug 8.
10
Hysteroscopic Morcellation Versus Loop Resection for Removal of Placental Remnants: A Randomized Trial.宫腔镜下旋切术与环形切除术治疗胎盘残留的随机对照试验
J Minim Invasive Gynecol. 2016 Nov-Dec;23(7):1172-1180. doi: 10.1016/j.jmig.2016.08.828. Epub 2016 Aug 30.